Dr. Mahdieh Mondanizadeh | Molecular Medicine | Best Researcher Award
Department of Biotechnology and Molecular Medicine, Faculty of Medicine, Arak University of Medical Sciences, Arak, Iran.
Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at Arak University of Medical Sciences, Iran. With a Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, her research focuses on the role of microRNAs in cancer diagnosis, treatment, and neurological disorders. Dr. Mondanizadeh has led numerous research projects and thesis works, contributing significantly to the understanding of miRNAs in various diseases, including gastric cancer, glioma, and spinal cord injuries. Her work is widely published in esteemed journals, highlighting her expertise in molecular biology and her commitment to advancing medical science. Dr. Mondanizadeh’s research has practical implications, such as the development of non-invasive diagnostic methods for cancer and the exploration of targeted therapies. Her international exposure, including a visit to the University of Adelaide, further underscores her global perspective and dedication to collaborative research.
Dr. Mahdieh Mondanizadeh is a highly qualified academic and researcher in the field of molecular medicine. She earned her Ph.D. in Medical Molecular Medicine from Hamedan University of Medical Sciences, Hamedan, Iran, where she conducted significant research from 2010 to 2014. Her doctoral thesis focused on evaluating the effect of miR-124 on transcription factors involved in the proliferation and differentiation of neuronal cells. Prior to her Ph.D., Dr. Mondanizadeh completed her M.Sc. in Medical Microbiology at Qom Islamic Azad University, Qom, Iran, from 2005 to 2007, further solidifying her foundation in microbiological research. She also holds a B.Sc. in Microbiology from Arak Azad University, Arak, Iran, which she completed between 2000 and 2004. In 2012, Dr. Mondanizadeh expanded her expertise through a visitorship at the University of Adelaide, Australia, enriching her research experience and international collaboration skills.
Dr. Mahdieh Mondanizadeh is an Associate Professor of Molecular Medicine at the Department of Biotechnology, Arak University of Medical Sciences, Iran. Since joining the institution in 2015, she has made significant contributions to the field of molecular medicine, focusing on the role of microRNAs in cancer diagnosis and treatment. Dr. Mondanizadeh has successfully led numerous research projects, including the development of novel diagnostic assays and the investigation of miRNA-related gene expression in various diseases. Her expertise extends to the study of molecular pathways in cancer, spinal cord injuries, and neurodegenerative diseases. Additionally, she has collaborated with international researchers and published extensively in high-impact journals. Her work is recognized for its innovation and potential to influence future medical treatments, making her a respected figure in the scientific community.
Mahdieh Mondanizadeh’s research interests are deeply rooted in molecular medicine, with a particular focus on the role of microRNAs (miRNAs) in various human diseases. Her work extensively explores the regulatory functions of miRNAs in cancer, neurological disorders, and infectious diseases, aiming to uncover their potential as diagnostic biomarkers and therapeutic targets. Mondanizadeh is especially interested in the molecular mechanisms underlying cancer progression, including the role of miRNAs in signal transduction pathways and gene expression regulation. Her research also extends to the study of miRNA involvement in spinal cord injuries, neurodegenerative diseases, and reproductive health issues. Additionally, she investigates the therapeutic potential of natural compounds and their effects on miRNA expression and cancer treatment. Through her research, Mondanizadeh contributes to the development of novel diagnostic tools and targeted therapies, advancing the field of personalized medicine.
Mahdieh Mondanizadeh is a highly skilled researcher with extensive expertise in molecular medicine and microbiology. Her research skills are demonstrated through her successful management of numerous projects focused on the role of microRNAs in cancer, neurodegenerative diseases, and infectious diseases. She excels in designing and conducting complex experiments, particularly those involving gene expression analysis, miRNA profiling, and the development of diagnostic assays. Her proficiency in molecular techniques such as real-time PCR, immunohistochemistry, and cell culture is complemented by her strong analytical abilities, allowing her to interpret data with precision and contribute to high-impact publications. Additionally, her collaborative approach and leadership in multidisciplinary research projects highlight her ability to integrate various scientific disciplines. Mondanizadeh’s commitment to advancing molecular medicine is further evidenced by her active participation in grant writing and project management, ensuring the successful completion and dissemination of her research findings.
Awards and Recognition
Dr. Mahdieh Mondanizadeh has garnered significant recognition for her impactful contributions to the field of molecular medicine and biotechnology. As an Associate Professor at Arak University of Medical Sciences, she has received multiple research grants and led numerous projects focusing on the role of microRNAs in various diseases, particularly cancer. Her innovative work in non-invasive cancer diagnostics and therapeutic strategies has earned her acclaim both nationally and internationally. Dr. Mondanizadeh has published extensively in high-impact journals, highlighting her research excellence and commitment to advancing medical science. She has also been invited to present her findings at prestigious conferences, further cementing her reputation as a leading researcher in her field. Her dedication to mentoring students and fostering a collaborative research environment has also been recognized, making her a respected figure in the academic community.
Mahdieh Mondanizadeh is a strong candidate for the Best Researcher Award due to her extensive research achievements, leadership in scientific projects, and significant contributions to the understanding of molecular mechanisms in disease. Enhancing the application and impact of her research findings and expanding her international collaborations could further bolster her candidacy. Overall, her work positions her as a deserving contender for this prestigious recognition.
Publications Top Notes
- MiRNAs related in signaling pathways of women’s reproductive diseases: an overview
- Authors: M. Bagheri, B. Khansarinejad, M. Mondanizadeh, M. Azimi, S. Alavi
- Year: 2024
- A systems biology approach and in vitro experiment indicated Rapamycin targets key cancer and cell cycle-related genes and miRNAs in triple-negative breast cancer cells
- Authors: A. Tafti, S. Shojaei, H. Zali, S. Mohammadi-Yeganeh, M. Mondanizadeh
- Year: 2023
- Citations: 2
- Assessment of efficacy of carboxytherapy in management of skin aging through evaluation of gene expression profile: a 2-split randomized clinical trial
- Authors: N. Bagherani, A. Firooz, A. Ghanadan, M. Mondanizadeh, G. Tavoosidana
- Year: 2023
- Hsa-miR-15b-5p/miR-195-5p Controls Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells Through Regulating Indian Hedgehog Expression
- Authors: S. Harimi, B. Khansarinejad, F. Fesahat, M. Mondanizadeh
- Year: 2023
- Optimizing a Calorimetric Method for Quantitative Assessment of Alkaline Phosphatase to confirm the Osteogenic Differentiation of Mesenchymal Stem Cell
- Authors: S. Harimi, F. Zare, F. Fesahat, M. Mondanizadeh
- Year: 2023
- The role of microRNAs in diseases and related signaling pathways
- Authors: A. Vaghf, B. Khansarinejad, E. Ghaznavi-Rad, M. Mondanizadeh
- Year: 2022
- Citations: 9
- Low Frequency of Adenovirus, Rotavirus, and Norovirus in Pediatric Diarrheal Samples from Central Iran
- Authors: E. Abbasi, M. Mondanizadeh, A. van Belkum, E. Ghaznavi-Rad
- Year: 2022
- Citations: 3
- The role of miRNAs as a big master regulator of signaling pathways involved in lymphoblastic leukemia
- Authors: M. Bagheri, P.Z. Sarabi, M. Mondanizadeh
- Year: 2022
- Citations: 3
- A Review of the Function of Circulating Cell Free miRNAs as Promising Biomarkers in Cancer Diagnosis, Treatment, and Metastasis
- Authors: M. Zand, M. Mondanizadeh
- Year: 2022
- Pap Smear miR-92a-5p and miR-155-5p as Potential Diagnostic Biomarkers of Squamous Intraepithelial Cervical Cancer
- Authors: T. Azimi, M. Paryan, M. Mondanizadeh, H. Sarmadian, A. Zamani
- Year: 2021
- Citations: 8